Regulatory sanctions for ethically relevant GCP violations

Rosemarie de la Cruz Bernabe, Ghislaine J. M. W. van Thiel, Nancy S. Breekveldt, Christine C. Gispen, Johannes J. M. van Delden

Research output: Contribution to journalReview articlepeer-review

2 Citations (Scopus)


Although EU inspectors and clinical assessors are mandated to identify and act upon ethical issues, regulators lack guidance on how this can be done. Hence, we propose a four-step regulatory approach on ethically relevant GCP violation findings. The first step is identification of the ethical issue. Next is analysis [i.e., identifying the gravity (intensity or severity) and the magnitude (amount and duration) of the ethics violation as well as the responsible person(s) or entity or entities]. The third step is evaluation, (i.e., the process of deliberating to determine the significance of the ethics violation, with the intention of identifying the most reasonable sanction and/or corrective or reparative action). Last is decision-making or the process of choosing and implementing a regulatory course of action.

Original languageEnglish
Pages (from-to)2116-2119
Number of pages4
JournalDrug Discovery Today
Issue number11
Publication statusPublished - Nov 2019


Dive into the research topics of 'Regulatory sanctions for ethically relevant GCP violations'. Together they form a unique fingerprint.

Cite this